Douglas E. Murphy

921 citations

16 papers · 355 indexed · h-index 10

Organic Chemistry top 10%
- Quinazolinone synthesis and applications 5
- Synthesis and Reactivity of Heterocycles 3
- Synthesis and Biological Evaluation 3
- Synthesis and Characterization of Heterocyclic Compounds 2
Hepatology
- Hepatitis C virus research 3
Molecular Biology
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Chemical Synthesis and Analysis 3
Computational Theory and Mathematics
Infectious Diseases
- HIV/AIDS drug development and treatment 3

Co-authors: Yuefen Zhou Zhongxiang Sun V. Gregor Benjamin K. Ayida Daniel Wall Jamie M. Froelich Stephen E. Webber Geoffrey C. Winters
Cited by: Organic Chemistry Hepatology Molecular Biology
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Tetrahedron Letters (2 papers)Synthesis (2 papers)
Partner nations: United States

In The Last Decade

Douglas E. Murphy

16 papers receiving 325 citations

Peers

Countries citing papers authored by Douglas E. Murphy

Since Specialization

Citations

This map shows the geographic impact of Douglas E. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Murphy more than expected).

Fields of papers citing papers by Douglas E. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Murphy. The network helps show where Douglas E. Murphy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas E. Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas E. Murphy Line = papers co-authored together Douglas E. Murphy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Last Futures: Nature, Technology and the End of Architecture Douglas E. Murphy	2016	5
2	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich,Maria Phyllis Mocock,David A. Ellis,Qing Han,Ruhi Kamran,Charles R. Kissinger,Laurie A. LeBrun,Lian‐Sheng Li,Douglas E. Murphy,Genevieve Calbrid,Rupal Patel,Frank Ruebsam,Maria V. Sergeeva,Amit Shah,Richard E. Showalter,Chinh Van Tran,S. B. Lee,Stephen E. Webber,co-promotor Muladi,Yuefen Zhou	2008	20
3	Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Chun Yuen Chow,Douglas E. Murphy,Zhongxiang Sun,敦子樋田,Jamie M. Froelich,Stephen E. Webber,Thomas Hermann,Daniel Wall	2008	9
4	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Lian‐Sheng Li,Peter S. Dragovich,Douglas E. Murphy,Chinh Van Tran,Frank Ruebsam,Stephen E. Webber,Amit Shah,S. B. Lee,April M. Averill,Richard E. Showalter,Rupal Patel,Qing Han,Qiang Zhao,Thomas Hermann,Charles R. Kissinger,Laurie A. LeBrun,Maria V. Sergeeva	2008	18
5	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Stephen E. Webber,Douglas E. Murphy,Lian‐Sheng Li,Peter S. Dragovich,Chinh Van Tran,Zhongxiang Sun,Frank Ruebsam,Amit Shah,S. B. Lee,Richard E. Showalter,Rupal Patel,Bin Li,Qiang Zhao,Qing Han,Thomas Hermann,Charles R. Kissinger,Laurie A. LeBrun,Maria V. Sergeeva,co-promotor Muladi	2008	26
6	Efficient synthesis of (1R,2S) and (1S,2R)-2-aminocyclopentanecarboxylic acid ethyl ester derivatives in enantiomerically pure form Tetrahedron Asymmetry ·Peter S. Dragovich,Douglas E. Murphy,Walid Mehanna,Sun Hee Kim,Lian‐Sheng Li,Frank Ruebsam,Zhongxiang Sun,Chinh Van Tran,Alan X. Xiang,Yuefen Zhou	2008	6
7	Regiospecific Synthesis of Novel 6-Amino-5-hydroxypyridazin-3(2H)-ones Synthesis ·Peter S. Dragovich,Maria Phyllis Mocock,Walid Mehanna,David Ellis,Lian‐Sheng Li,Douglas E. Murphy,Frank Ruebsam,Chinh Van Tran,Yuefen Zhou	2008	2
8	Efficient Large-Scale Synthesis of 2-Amino-5-methanesulfonylaminobenzenesulfonamide Synthetic Communications ·Peter S. Dragovich,Douglas E. Murphy,Chinh Van Tran,Frank Ruebsam	2008	3
9	Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl esters Tetrahedron Letters ·Douglas E. Murphy,Peter S. Dragovich,Benjamin K. Ayida,敦子樋田,Lian‐Sheng Li,Frank Ruebsam,Nebojša Stanković,Zhongxiang Sun,Jingjing Zhao,Yuefen Zhou	2007	20
10	Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1Exploration of Pyridazinone 4-Substituent Variation Antiviral Research ·Mohamed S. Elghreeb,L LI,S. E. Webber,Peter S. Dragovich,Douglas E. Murphy,Díaz López,Frank Ruebsam,Amit Shah,S. B. Lee,Richard E. Showalter	2007	3
11	Synthesis of New Pyridazinone Derivatives: 2,6-Disubstituted 5-Hydroxy-3(2H)-pyridazinone-4-carboxylic Acid Ethyl Esters Synthesis ·Yuefen Zhou,Jon Hirsch,Jingjing Zhao,Peter S. Dragovich,Nebojša Stanković,敦子樋田,Douglas E. Murphy,Zhongxiang Sun,Chinh Tran,Benjamin K. Ayida,Frank Ruebsam,Stephen E. Webber	2007	1
12	Synthesis and SAR of 3,5-diamino-piperidine derivatives: Novel antibacterial translation inhibitors as aminoglycoside mimetics Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,V. Gregor,Benjamin K. Ayida,Geoffrey C. Winters,Zhongxiang Sun,Douglas E. Murphy,Л. М. Колобова,杜永亮,Jamie M. Froelich,Sarah Fish,Stephen E. Webber,Thomas Hermann,Daniel Wall	2006	119
13	Regiospecific synthesis of 1,5-disubstituted-1H-pyrazoles containing differentiated 3,4-dicarboxylic acid esters via Suzuki coupling of the corresponding 5-trifluoromethane sulfonates Tetrahedron ·Peter S. Dragovich,敦子樋田,Benjamin K. Ayida,Lian‐Sheng Li,Douglas E. Murphy,Frank Ruebsam,Zhongxiang Sun,Yuefen Zhou	2006	12
14	Structure-Guided Discovery of Novel Aminoglycoside Mimetics as Antibacterial Translation Inhibitors Antimicrobial Agents and Chemotherapy ·Yuefen Zhou,V. Gregor,Zhongxiang Sun,Benjamin K. Ayida,Geoffrey C. Winters,Douglas E. Murphy,Klaus B. Simonsen,Dionisios Vourloumis,Sarah Fish,Jamie M. Froelich,Daniel Wall,Thomas Hermann	2005	41
15	Novel parallel synthesis of N-(4-oxo-2-substituted-4H-quinazolin-3-yl)-substituted sulfonamides Tetrahedron Letters ·Yuefen Zhou,Douglas E. Murphy,Zhongxiang Sun,V. Gregor	2004	36
16	Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists Journal of Medicinal Chemistry ·Ernest Thomas Brooks,渡邊美樹,Javier González,V. Gregor,Roselyn Onyegbula,Atsuo Kuki,Shenghua Shi,田口俊之,Douglas E. Murphy,John W. Porter,Dan Kiel,Н. Я. Дрінь,Kenna Anderes,John M. May,Lotte Bjerre Knudsen,Jesper Lau	2001	34

About Douglas E. Murphy

Douglas E. Murphy is a scholar working on Organic Chemistry, Hepatology, Infectious Diseases, Microbiology and Molecular Biology, having authored 16 papers that have together received 355 indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Chemical Synthesis and Analysis (3 papers), Synthesis and Reactivity of Heterocycles (3 papers), Hepatitis C virus research (3 papers), HIV/AIDS drug development and treatment (3 papers), Synthesis and Biological Evaluation (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Organic Chemistry (223 citations), Hepatology (51 citations), Molecular Biology (162 citations), Computational Theory and Mathematics (34 citations) and Infectious Diseases (34 citations). Douglas E. Murphy has collaborated with scholars based in United States. Frequent co-authors include Yuefen Zhou, Zhongxiang Sun, V. Gregor, Benjamin K. Ayida, Daniel Wall, Jamie M. Froelich, Stephen E. Webber, Geoffrey C. Winters, Sarah Fish and Peter S. Dragovich. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Synthesis, Tetrahedron and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact